SCHEDULE: Kopernik Global Investors Discloses Concentrix Stake

Kopernik Global Investors, LLC and David B. Iben have jointly filed a Schedule 13G, reporting beneficial ownership of 5.3% of Concentrix Corporation's common shares.

Summary

• Kopernik Global Investors, LLC and David B. Iben have filed a joint Schedule 13G statement.
• This filing indicates their beneficial ownership of 3,241,584 shares of Concentrix Corporation's common stock.
• This represents 5.3% of the total outstanding common shares as of May 31, 2026.
• The filing is made in accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934.
• Kopernik Global Investors, LLC is identified as an investment adviser, and David B. Iben is its controlling member and Chief Investment Officer.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily administrative in nature, with no immediate positive or negative financial implications.

Positives

• Kopernik Global Investors, LLC and David B. Iben have disclosed their significant stake in Concentrix Corporation, providing transparency to the market.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a standard investment approach rather than a hostile takeover attempt.

Negatives

• No specific financial performance data or strategic updates are provided in this filing, limiting insights into the company's operational health.

Risks

• The filing does not explicitly mention any risks associated with the investment or the company's operations.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• Kopernik Global Investors, LLC and David B. Iben agree to be responsible for the timely filing of the Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein.
• David B. Iben grants Sarah L. Bertrand full power and authority to prepare, execute, and submit to the SEC any and all reports required or advisable under Section 13 or Section 16 of the Exchange Act or Rule 144.

Industry Context

StockSavvy.ai notes that this filing is a standard disclosure for significant institutional investors and does not inherently reflect on Concentrix Corporation's operational performance or industry standing.

Stakeholder Impact

• Shareholders gain transparency regarding a significant beneficial owner of Concentrix Corporation's common shares.
• The market receives information about Kopernik Global Investors, LLC's investment position, potentially influencing trading decisions.

Next Steps

• Kopernik Global Investors, LLC and David B. Iben will continue to file amendments to Schedule 13G as required by regulations.
• Sarah L. Bertrand will act as attorney-in-fact for electronic filings with the SEC on behalf of David B. Iben.

Key Dates

Keywords

Concentrix Corporation, Schedule 13G, Kopernik Global Investors, David B. Iben, beneficial ownership, investment adviser, common shares